UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
Therapeutic Application of Painless Nerve Growth Factor to Accelerate Endochondral Fracture Repair
Therapeutic Application of Painless Nerve Growth Factor to Accelerate Endochondral Fracture Repair is a funding opportunity from UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, up to 550847, closing July 31, 2027.
Jul 31, 2027
(365d left)Overview
ABSTRACT The long-term goal of this project is to develop and validate an injectable, biodegradable nanowire delivery platform for local and sustained release of a “painless” nerve growth factor (NGF) isoform to accelerate fracture healing in clinical scenarios of delayed healing. Approximately 15 million fracture…